Katsube K, Doi K, Fukumoto T, Fujikura Y, Shigetomi M, Kawai S
Department of Orthopedic Surgery, Yamaguchi University School of Medicine, Kogushi, Ube, Japan.
Transplantation. 1998 Sep 27;66(6):772-7. doi: 10.1097/00007890-199809270-00012.
The origin of Schwann cells and effect of a limited course of immunosuppression using cyclosporine (CsA) were examined in rat peripheral nerve allotransplants.
Phenotypes of Schwann cells in groups without, with continuing, and with limited (12 weeks) CsA treatment were examined immunohistochemically in allogeneically and syngeneically transplanted animals from 4 to 36 weeks after transplantation.
In the group receiving no CsA, little nerve regeneration was obtained; donor Schwann cells were rejected and replaced by recipient cells. In continuing and limited-course CsA groups, successful nerve regeneration was achieved at postoperative week 36, as was also observed in the syngeneic group. Schwann cells in the continuing CsA group remained donor-derived. In the limited-course CsA group, graft rejection and loss of function occurred after the withdrawal of CsA, and donor Schwann cells were replaced by recipient cells in the part of the graft where rejection had been complete. However, many donor Schwann cells remained at week 36, when the rejection response subsided.
Possible clinical use of a limited course of immunosuppression was supported by this demonstration of long term persistence of donor Schwann cells.
在大鼠外周神经同种异体移植中,研究了施万细胞的起源以及使用环孢素(CsA)进行有限疗程免疫抑制的效果。
对未接受CsA治疗、持续接受CsA治疗以及接受有限疗程(12周)CsA治疗的组,在移植后4至36周对同种异体和同基因移植动物的施万细胞表型进行免疫组织化学检查。
在未接受CsA治疗的组中,神经再生很少;供体施万细胞被排斥并被受体细胞取代。在持续使用CsA组和有限疗程CsA组中,术后36周实现了成功的神经再生,同基因组也观察到了这一情况。持续使用CsA组中的施万细胞仍来源于供体。在有限疗程CsA组中,停用CsA后发生移植物排斥和功能丧失,在移植物中排斥已完全发生的部分,供体施万细胞被受体细胞取代。然而,在排斥反应消退的36周时,许多供体施万细胞仍然存在。
供体施万细胞长期持续存在的这一证明支持了有限疗程免疫抑制在临床上的可能应用。